AU2012347468A1 - Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants - Google Patents

Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants Download PDF

Info

Publication number
AU2012347468A1
AU2012347468A1 AU2012347468A AU2012347468A AU2012347468A1 AU 2012347468 A1 AU2012347468 A1 AU 2012347468A1 AU 2012347468 A AU2012347468 A AU 2012347468A AU 2012347468 A AU2012347468 A AU 2012347468A AU 2012347468 A1 AU2012347468 A1 AU 2012347468A1
Authority
AU
Australia
Prior art keywords
opn
seq
variant
cancer
relative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012347468A
Other languages
English (en)
Inventor
Susan R. Rittling
Anja SERENA
Peter Langborg WEJSE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arla Foods AMBA
ADA Forsyth Institute Inc
Original Assignee
Arla Foods AMBA
Forsyth Dental Infirmary for Children Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arla Foods AMBA, Forsyth Dental Infirmary for Children Inc filed Critical Arla Foods AMBA
Publication of AU2012347468A1 publication Critical patent/AU2012347468A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2012347468A 2011-12-07 2012-12-07 Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants Abandoned AU2012347468A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161567899P 2011-12-07 2011-12-07
US61/567,899 2011-12-07
US201261673912P 2012-07-20 2012-07-20
US61/673,912 2012-07-20
EP12177329 2012-07-20
EP12177329.5 2012-07-20
PCT/US2012/068628 WO2013086459A1 (en) 2011-12-07 2012-12-07 Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants

Publications (1)

Publication Number Publication Date
AU2012347468A1 true AU2012347468A1 (en) 2014-06-26

Family

ID=48574961

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012347468A Abandoned AU2012347468A1 (en) 2011-12-07 2012-12-07 Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants

Country Status (12)

Country Link
US (1) US20150344534A1 (enExample)
EP (1) EP2788015A1 (enExample)
JP (1) JP2015500836A (enExample)
KR (1) KR20140104474A (enExample)
CN (1) CN104080472A (enExample)
AR (1) AR089136A1 (enExample)
AU (1) AU2012347468A1 (enExample)
BR (1) BR112014013565A2 (enExample)
CA (1) CA2858379A1 (enExample)
EA (1) EA201491010A1 (enExample)
WO (1) WO2013086459A1 (enExample)
ZA (1) ZA201404920B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014286123B2 (en) * 2013-07-05 2019-02-28 Arla Foods Amba Mammalian milk osteopontin for enhancing immune responsiveness
EP4326758A4 (en) * 2021-04-20 2025-03-19 University of Cincinnati A vaccine adjuvant for infectious diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888552A (en) * 1988-04-29 1999-03-30 Immunotec Research Corporation Ltd. Anti-cancer therapeutic compositions containing whey protein concentrate
IL106576A (en) * 1992-08-13 2000-08-13 Immunotec Res Corp Ltd Anti-cancer therapeutic compositions for prophylaxis or for treatment of cancer
AU773350B2 (en) * 1999-04-15 2004-05-20 Children's Medical Center Corporation Methods and compositions for modulating an immune response
US7259243B2 (en) * 2000-01-07 2007-08-21 Arla Foods Amba Process for isolation of osteopontin from milk
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
RU2379975C2 (ru) * 2003-09-18 2010-01-27 Арла Фудс Амба Добавка в состав для детского питания
SM200600031B (it) * 2006-10-06 2009-05-11 Gianluca Mech Integratore alimentare con attivatore proteico
ES2538362T3 (es) * 2007-10-16 2015-06-19 Ventana Medical Systems, Inc. Clasificación, estadificación y pronóstico del cáncer mediante el uso de osteopontina-C

Also Published As

Publication number Publication date
EP2788015A1 (en) 2014-10-15
US20150344534A1 (en) 2015-12-03
WO2013086459A1 (en) 2013-06-13
AR089136A1 (es) 2014-07-30
KR20140104474A (ko) 2014-08-28
ZA201404920B (en) 2015-12-23
CA2858379A1 (en) 2013-06-13
EA201491010A1 (ru) 2015-01-30
CN104080472A (zh) 2014-10-01
JP2015500836A (ja) 2015-01-08
BR112014013565A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
EP3630942B1 (en) Compositions comprising bacterial strain
JP6312919B2 (ja) 細菌株を含む組成物
AU2017201718B2 (en) Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
KR20190059297A (ko) 고-이동성 군 박스 1 돌연변이체
EP3319618B1 (en) Process for producing egg yolk with high content of af-16
JP2022511653A (ja) インターアルファインヒビタータンパク質及びその使用方法
US20250213649A1 (en) Peptide having anti-inflammatory and anti-fibrotic activities and use thereof
AU2012347468A1 (en) Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants
US20150190460A1 (en) Osteopontin peptide fragments for use in suppression or prevention of tumor growth
KR102349013B1 (ko) 멜라토닌을 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물
CN112823808B (zh) 用于制备治疗上皮细胞癌的医药组合物及其用途
CA2832376A1 (en) Drug containing recombinant mistletoe lectins for treating malignant melanoma
KR101552021B1 (ko) Rab5 발현 저해 물질을 유효 성분으로 포함하는 파브리 질환의 예방 또는 치료용 조성물
EP4005583A1 (en) Cp2c-targeting peptide-based anticancer agent
WO2023072968A1 (en) Compositions comprising bacterial strains
KR101608141B1 (ko) 클라스린 발현 저해 물질을 유효 성분으로 포함하는 파브리 질환의 예방 또는 치료용 조성물
CN116509918A (zh) 三种天然产物组合在制备治疗非酒精性脂肪肝药物中的应用
HK1254166B (zh) 包含细菌菌株的组合物
KR20150113270A (ko) 패혈증에 의한 염증성 질환의 예방 및 치료용 약학적 조성물

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted